GB201620516D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB201620516D0
GB201620516D0 GBGB1620516.3A GB201620516A GB201620516D0 GB 201620516 D0 GB201620516 D0 GB 201620516D0 GB 201620516 A GB201620516 A GB 201620516A GB 201620516 D0 GB201620516 D0 GB 201620516D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1620516.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mexichem Fluor SA de CV
Original Assignee
Mexichem Fluor SA de CV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mexichem Fluor SA de CV filed Critical Mexichem Fluor SA de CV
Priority to GBGB1620516.3A priority Critical patent/GB201620516D0/en
Publication of GB201620516D0 publication Critical patent/GB201620516D0/en
Priority to JP2019515269A priority patent/JP6781830B2/en
Priority to US16/334,151 priority patent/US11260052B2/en
Priority to ES21183138T priority patent/ES2949975T3/en
Priority to CN202310227306.XA priority patent/CN116270640A/en
Priority to CN201780057065.1A priority patent/CN109715160A/en
Priority to EP21183138.3A priority patent/EP3909582B1/en
Priority to PCT/GB2017/052757 priority patent/WO2018051128A1/en
Priority to CN202110262649.0A priority patent/CN113288869A/en
Priority to AU2017328905A priority patent/AU2017328905C1/en
Priority to CA3037080A priority patent/CA3037080C/en
Priority to MX2019003105A priority patent/MX2019003105A/en
Priority to ES17777634T priority patent/ES2891579T3/en
Priority to BR112019005080A priority patent/BR112019005080A2/en
Priority to EP17777634.1A priority patent/EP3515441B1/en
Priority to MX2021010022A priority patent/MX2021010022A/en
Priority to AU2020202580A priority patent/AU2020202580B2/en
Priority to JP2020140692A priority patent/JP6972256B2/en
Priority to US17/577,824 priority patent/US20220133709A1/en
Ceased legal-status Critical Current

Links

GBGB1620516.3A 2016-09-19 2016-12-02 Pharmaceutical composition Ceased GB201620516D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB1620516.3A GB201620516D0 (en) 2016-12-02 2016-12-02 Pharmaceutical composition
EP17777634.1A EP3515441B1 (en) 2016-09-19 2017-09-18 Pharmaceutical composition comprising indacaterol
CN202110262649.0A CN113288869A (en) 2016-09-19 2017-09-18 Pharmaceutical composition
CA3037080A CA3037080C (en) 2016-09-19 2017-09-18 Stable pharmaceutical compositions comprising indacaterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis)
ES21183138T ES2949975T3 (en) 2016-09-19 2017-09-18 Pharmaceutical composition comprising indacaterol
CN202310227306.XA CN116270640A (en) 2016-09-19 2017-09-18 Pharmaceutical composition
CN201780057065.1A CN109715160A (en) 2016-09-19 2017-09-18 Pharmaceutical composition
EP21183138.3A EP3909582B1 (en) 2016-09-19 2017-09-18 Pharmaceutical composition comprising indacaterol
PCT/GB2017/052757 WO2018051128A1 (en) 2016-09-19 2017-09-18 Pharmaceutical composition
JP2019515269A JP6781830B2 (en) 2016-09-19 2017-09-18 Pharmaceutical composition
AU2017328905A AU2017328905C1 (en) 2016-09-19 2017-09-18 Pharmaceutical composition
US16/334,151 US11260052B2 (en) 2016-09-19 2017-09-18 Pharmaceutical composition
MX2019003105A MX2019003105A (en) 2016-09-19 2017-09-18 Pharmaceutical composition.
ES17777634T ES2891579T3 (en) 2016-09-19 2017-09-18 Pharmaceutical composition
BR112019005080A BR112019005080A2 (en) 2016-09-19 2017-09-18 pharmaceutical composition, sealed container, metered dose inhaler, and methods for treating a patient suffering or likely to suffer from a respiratory disorder, to improve the stability of a pharmaceutical composition, to increase the stabilization time of a pharmaceutical composition, to improve the aerosolization performance of a pharmaceutical composition and to reduce the global warming potential of a pharmaceutical composition.
MX2021010022A MX2021010022A (en) 2016-09-19 2019-03-15 Pharmaceutical composition.
AU2020202580A AU2020202580B2 (en) 2016-09-19 2020-04-16 Pharmaceutical composition
JP2020140692A JP6972256B2 (en) 2016-09-19 2020-08-24 Pharmaceutical composition
US17/577,824 US20220133709A1 (en) 2016-09-19 2022-01-18 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1620516.3A GB201620516D0 (en) 2016-12-02 2016-12-02 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB201620516D0 true GB201620516D0 (en) 2017-01-18

Family

ID=58159709

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1620516.3A Ceased GB201620516D0 (en) 2016-09-19 2016-12-02 Pharmaceutical composition

Country Status (1)

Country Link
GB (1) GB201620516D0 (en)

Similar Documents

Publication Publication Date Title
IL265360A (en) Pharmaceutical composition
IL265260B (en) Pharmaceutical composition
IL271986A (en) Pharmaceutical composition
IL262654A (en) Pharmaceutical composition
IL265349A (en) Pharmaceutical composition
GB201712159D0 (en) Pharmaceutical composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201506526D0 (en) Medicinal composition
GB201521462D0 (en) Pharmaceutical composition
GB201719447D0 (en) Pharmaceutical composition
IL272419A (en) Pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
HK1245073A1 (en) Pharmaceutical compositions
PL3454838T3 (en) Pharmaceutical composition
GB201615917D0 (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
IL263999A (en) Pharmaceutical compositions
EP3727485C0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
IL265436B (en) Pharmaceutical composition
ZA201705782B (en) Pharmaceutical compositions
PL3424500T3 (en) Pharmaceutical composition comprising famitinib
IL265428A (en) Pharmaceutical composition
PT3476391T (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)